发明名称 |
Prohemostatic proteins for the treatment of bleeding |
摘要 |
The present invention relates to recombinant FXa polypeptides that can be used as antidotes to completely or partially reverse an anti-coagulant effect of a coagulation inhibitor in a subject, preferably a direct factor Xa inhibitor. Disclosed herein are recombinant factor Xa proteins and a method of completely or partially reversing an anti-coagulant effect of a coagulation inhibitor in a subject. |
申请公布号 |
AU2015268149(A1) |
申请公布日期 |
2016.12.08 |
申请号 |
AU20150268149 |
申请日期 |
2015.05.26 |
申请人 |
Academisch Ziekenhuis Leiden |
发明人 |
Verhoef, Daniel;Reitsma, Pieter H.;Bos, Mettine H.A. |
分类号 |
C12N9/64;C07K14/46 |
主分类号 |
C12N9/64 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|